Smith Hayes Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.72M Sell
22,890
-368
-2% -$27.7K 0.35% 79
2015
Q4
$1.79M Buy
23,258
+2
+0% +$151 0.38% 76
2015
Q3
$1.55M Sell
23,256
-723
-3% -$53.3K 0.34% 89
2015
Q2
$1.77M Buy
23,979
+1
+0% +$76 0.35% 84
2015
Q1
$1.87M Buy
23,978
+2,488
+12% +$189K 0.37% 79
2014
Q4
$1.55M Sell
21,490
-161
-0.7% -$11.2K 0.32% 98
2014
Q3
$1.34M Sell
21,651
-1,595
-7% -$101K 0.31% 96
2014
Q2
$1.48M Buy
23,246
+340
+1% +$20.7K 0.35% 86
2014
Q1
$1.41M Buy
22,906
+4
+0% +$233 0.35% 85
2013
Q4
$1.31M Sell
22,902
-323
-1% -$18.3K 0.43% 74
2013
Q3
$1.24M Sell
23,225
-2,563
-10% -$138K 0.47% 69
2013
Q2
$1.33M Buy
+25,788
New +$1.27M 0.55% 60

Other funds holding MDT

Smith Hayes Advisers's MDT Position: Q1 2016 in Review

Smith Hayes Advisers reduced its Medtronic (MDT) stake by 1.6% in Q1 2016, selling an estimated $27.7K and leaving 22,890 shares worth $1.72M. The position accounts for 0.35% of the portfolio, ranked #79.

Smith Hayes Advisers first reported a position in MDT in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.87M in Q1 2015. 1,240 funds tracked by Wall St. Rank hold MDT as of Q1 2016.

  • Smith Hayes Advisers held 22,890 shares of Medtronic worth $1.72M as of Q1 2016.
  • Smith Hayes Advisers sold 368 Medtronic shares in Q1 2016, an estimated $27.7K.
  • Medtronic made up 0.35% of Smith Hayes Advisers's portfolio in Q1 2016, its #79 holding.
  • Smith Hayes Advisers first reported a position in Medtronic in Q2 2013 and has held it in 12 quarters since.
  • Smith Hayes Advisers's Medtronic position peaked at $1.87M in Q1 2015.
  • 1,240 funds tracked by Wall St. Rank held Medtronic as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.